Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of enoxaparin injection duration on injection pain in orthopedic inpatients
IRCT2016112614333N62Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of enoxaparin in pain, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Injection pain severity. Started Feb 2017; status: completed.
02
Drugs
enoxaparin
03
Conditions
pain
Beyond the preview
Go deeper on IRCT2016112614333N62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016112614333N62.